| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.16 | 0.008 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.21 | 0.008 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.16 | 0.01 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.47 | 0.01 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.15 | 0.01 |